Patrizia Loi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Patrizia Loi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jacques Devière
Hospital Erasme, Bruxelles, Belgium
2 shared publications Jean Closset
2 shared publications- A. Limgba
Department of Surgery and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
1 shared publication Arnaud Lemmers
Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium
1 shared publication- Arnaud Lemmers
Erasmus Hospital, Brussels, Belgium
1 shared publication - Basile Essola
Department of Surgery and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
1 shared publication
Latest Publications
- 31 January 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (9) , 6558-6566
Prospective, randomized clinical trial of laparoscopic totally extraperitoneal inguinal hernia repair using conventional versus custom-made (mosquito) mesh performed in Cameroon: a short-term outcomes
Background Adverse economic conditions often prevent the widespread implementation of modern surgical techniques in third world countries such as in Sub-Sahara Africa. Aim of the study To demonstrate that a modern technique (laparoscopic totally extraperitoneal inguinal hernioplasty [TEP]) can safely be performed at significantly lower cost using inexpensive mesh material. Settings Douala University Hospital Gynecology, Obstetrics and Pediatrics and two affiliated centers, Ayos Regional Hospital and Edéa Regional Hospital in Cameroon. Patients and methods Prospective randomized controlled trial (RCT) of consecutive adult patients presenting with primary inguinal hernia treated by TEP, comparing implantation of sterilized mosquito mesh (MM) with conventional polypropylene mesh (CM). Primary endpoints were peroperative, early and midterm postoperative complications and hernia recurrence at 30 months. Results Sixty-two patients (48 males) were randomized to MM (n = 32) or CM (n = 30). Groups were similar in age distribution and occupational features. Peroperative and early outcomes differed in terms of conversion rate (2/32 MM) due to external (electrical power supply) factors and mesh removal for early obstruction (1/30 CM). No outcome differences, including no recurrences, were noted after a median follow-up of 21 months. Conclusion In this RCT with medium-term follow-up, TEP performed with MM appears not inferior to CM.
- 31 January 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (9) , 6558-6566
Prospective, randomized clinical trial of laparoscopic totally extraperitoneal inguinal hernia repair using conventional versus custom-made (mosquito) mesh performed in Cameroon: a short-term outcomes
Background Adverse economic conditions often prevent the widespread implementation of modern surgical techniques in third world countries such as in Sub-Sahara Africa. Aim of the study To demonstrate that a modern technique (laparoscopic totally extraperitoneal inguinal hernioplasty [TEP]) can safely be performed at significantly lower cost using inexpensive mesh material. Settings Douala University Hospital Gynecology, Obstetrics and Pediatrics and two affiliated centers, Ayos Regional Hospital and Edéa Regional Hospital in Cameroon. Patients and methods Prospective randomized controlled trial (RCT) of consecutive adult patients presenting with primary inguinal hernia treated by TEP, comparing implantation of sterilized mosquito mesh (MM) with conventional polypropylene mesh (CM). Primary endpoints were peroperative, early and midterm postoperative complications and hernia recurrence at 30 months. Results Sixty-two patients (48 males) were randomized to MM (n = 32) or CM (n = 30). Groups were similar in age distribution and occupational features. Peroperative and early outcomes differed in terms of conversion rate (2/32 MM) due to external (electrical power supply) factors and mesh removal for early obstruction (1/30 CM). No outcome differences, including no recurrences, were noted after a median follow-up of 21 months. Conclusion In this RCT with medium-term follow-up, TEP performed with MM appears not inferior to CM.
- 5 September 2015
- Published by Springer Nature in Obesity Surgery
- Vol. 25 (11) , 2190-2199
Transluminal or Percutaneous Endoscopic Drainage and Debridement of Abscesses After Bariatric Surgery: a Case Series
Since redo surgery is associated with a high risk of morbidity and mortality after bariatric surgery in case of leakage, we sought to evaluate whether endoscopic drainage and debridement of collections following bariatric surgery is an efficient step-up approach to the management of these complications.
- 5 September 2015
- Published by Springer Nature in Obesity Surgery
- Vol. 25 (11) , 2190-2199
Transluminal or Percutaneous Endoscopic Drainage and Debridement of Abscesses After Bariatric Surgery: a Case Series
Since redo surgery is associated with a high risk of morbidity and mortality after bariatric surgery in case of leakage, we sought to evaluate whether endoscopic drainage and debridement of collections following bariatric surgery is an efficient step-up approach to the management of these complications.
- 20 January 2015
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 47 (S 01) , E83-E84
Mid-gut bleeding due to a chronic splanchnic vascular stricture with secondary portal hypertension after gastric bypass
A 41-year-old man presented with a 24-hour history of melena and exacerbated epigastric pain 6 years after undergoing a laparoscopic Roux-en-Y gastric bypass for morbid obesity. He had been experiencing recurrent abdominal pain and episodes of melena in the preceding months. His past medical history also included protein C deficiency and a pulmonary embolism treated with anticoagulant therapy, which had been stopped 6 months earlier following bleeding from an anastomotic ulcer. Physical examination revealed low blood pressure, tachycardia, and epigastric pain, without rebound tenderness. The patient had lost 42 kg since the laparoscopic Roux-en-Y gastric bypass. Laboratory data disclosed an acute fall in the hemoglobin level (7.4 g/dL) and increased blood urea nitrogen (50 mg/dL). Esophagogastroduodenoscopy showed severe portal hypertensive gastropathy of the fundal pouch, signs of fresh bleeding, and normal jejunal mucosa ([Fig. 1]). Emergency computed tomographic angiography showed a proximal mesenteric torsion and occlusion of the superior mesenteric vein with signs of portal hypertension ([Fig. 2]). The patient underwent a laparotomy, which revealed an internal hernia in the Petersen space. The internal hernia was reduced without bowel resection. Two weeks after closure of the Petersen space, abdominal computed tomography disclosed persistence of the superior mesenteric vein occlusion ([Fig. 3]). Repermeabilization of the superior mesenteric vein ([Fig. 4]) was achieved after 3 months of anticoagulant therapy, without complications or recurrence of the abdominal pain. Internal hernias are more common following laparoscopic Roux-en-Y gastric bypass than after open surgery [1]. In order to minimize this risk, several authors suggest closure of the mesenteric defects [2]. Actually, complete mesenteric closure after laparoscopic Roux-en-Y gastric bypass is still debated [3] [4]. Digestive bleeding related to a chronic splanchnic vascular stricture with secondary portal hypertension after laparoscopic Roux-en-Y gastric bypass has never been described. Surgeons and endoscopists should be aware of this rare complication. Endoscopy_UCTN_Code_CCL_1AC_2AD
- 20 January 2015
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 47 (S 01) , E83-E84
Mid-gut bleeding due to a chronic splanchnic vascular stricture with secondary portal hypertension after gastric bypass
A 41-year-old man presented with a 24-hour history of melena and exacerbated epigastric pain 6 years after undergoing a laparoscopic Roux-en-Y gastric bypass for morbid obesity. He had been experiencing recurrent abdominal pain and episodes of melena in the preceding months. His past medical history also included protein C deficiency and a pulmonary embolism treated with anticoagulant therapy, which had been stopped 6 months earlier following bleeding from an anastomotic ulcer. Physical examination revealed low blood pressure, tachycardia, and epigastric pain, without rebound tenderness. The patient had lost 42 kg since the laparoscopic Roux-en-Y gastric bypass. Laboratory data disclosed an acute fall in the hemoglobin level (7.4 g/dL) and increased blood urea nitrogen (50 mg/dL). Esophagogastroduodenoscopy showed severe portal hypertensive gastropathy of the fundal pouch, signs of fresh bleeding, and normal jejunal mucosa ([Fig. 1]). Emergency computed tomographic angiography showed a proximal mesenteric torsion and occlusion of the superior mesenteric vein with signs of portal hypertension ([Fig. 2]). The patient underwent a laparotomy, which revealed an internal hernia in the Petersen space. The internal hernia was reduced without bowel resection. Two weeks after closure of the Petersen space, abdominal computed tomography disclosed persistence of the superior mesenteric vein occlusion ([Fig. 3]). Repermeabilization of the superior mesenteric vein ([Fig. 4]) was achieved after 3 months of anticoagulant therapy, without complications or recurrence of the abdominal pain. Internal hernias are more common following laparoscopic Roux-en-Y gastric bypass than after open surgery [1]. In order to minimize this risk, several authors suggest closure of the mesenteric defects [2]. Actually, complete mesenteric closure after laparoscopic Roux-en-Y gastric bypass is still debated [3] [4]. Digestive bleeding related to a chronic splanchnic vascular stricture with secondary portal hypertension after laparoscopic Roux-en-Y gastric bypass has never been described. Surgeons and endoscopists should be aware of this rare complication. Endoscopy_UCTN_Code_CCL_1AC_2AD
- 30 June 2010
- Vol. 57 (98) , 344-8
Neuroendocrine tumors of pancreas: how can we apply the 2006 TNM proposal?
In 2006, a TNM system for foregut neuroendocrine tumors has been proposed. Our study aimed to present the management of neuroendocrine tumors of pancreas according to this classification and to highlight some of its limitations. Clinical, biochemical, radiological, surgical and pathological data were retrospectively collected on 22 consecutives patients, who underwent surgery for neuroendocrine tumors of pancreas between November, 1991 and September, 2005. These data were used to set the TNM. After excluding 5 patients, the remaining 17 patients were analyzed. In 9 patients, with a mean age of 39 years, tumors were benign with a mean size of 1.8 cm, classed at stage I-IIa, whereas for 8 patients with a mean age of 57 years, tumors were malignant with a mean size of 6cm and were classed at stage IIb-IV. There were 3 deaths in stage IIb-IV, and none in stage I-IIa. TNM may be considered as a useful tool for prognostic stratification, but true benign tumors need to be excluded in order to improve the classification. Size and age appeared as variables affecting malignant behavior and the prognosis.
- 30 June 2010
- Vol. 57 (98) , 344-8
Neuroendocrine tumors of pancreas: how can we apply the 2006 TNM proposal?
In 2006, a TNM system for foregut neuroendocrine tumors has been proposed. Our study aimed to present the management of neuroendocrine tumors of pancreas according to this classification and to highlight some of its limitations. Clinical, biochemical, radiological, surgical and pathological data were retrospectively collected on 22 consecutives patients, who underwent surgery for neuroendocrine tumors of pancreas between November, 1991 and September, 2005. These data were used to set the TNM. After excluding 5 patients, the remaining 17 patients were analyzed. In 9 patients, with a mean age of 39 years, tumors were benign with a mean size of 1.8 cm, classed at stage I-IIa, whereas for 8 patients with a mean age of 57 years, tumors were malignant with a mean size of 6cm and were classed at stage IIb-IV. There were 3 deaths in stage IIb-IV, and none in stage I-IIa. TNM may be considered as a useful tool for prognostic stratification, but true benign tumors need to be excluded in order to improve the classification. Size and age appeared as variables affecting malignant behavior and the prognosis.